Stock News
Unleashing the Power of Intelligence: Intelligent Bio Solutions Reports Impressive First Quarter Revenue for Fiscal 2025
Intelligent Bio Solutions Inc. Reports Strong Quarterly Revenue Growth New York, Oct. 29, 2024 Intelligent Bio Solutions Inc. (Nasdaq: INBS) has recently announced promising unaudited revenue results for the fiscal first quarter ended September 30, 2024. The company reported a 10% year-on-year increase and a 20% quarter-on-quarter increase in revenue, totaling approximately $0.87 million for…
Mark your calendars! Electromed Inc. to Unveil First Quarter Fiscal 2025 Financial Results on November 12, 2024 at 5:00 PM ET
Exciting News from Electromed, Inc. Get Ready for the Big Announcement! Hey there, readers! Do we have some exciting news for you today! Electromed, Inc., a leading provider of innovative airway clearance technologies, has just announced that they will be releasing their financial results for the fiscal 2025 first quarter on November 12, 2024. If…
FDA Advisory Panel for IceCure’s Prosense Marketing Authorization Receives Overwhelming Public Response from Stakeholders
IceCure ProSense® Cryoablation System: A Game-Changer for Breast Cancer Treatment Exciting News from FDA Advisory Panel Exciting news has emerged from the FDA Advisory Panel regarding the De Novo marketing submission of the IceCure ProSense® Cryoablation System for early-stage low risk breast cancer. Scheduled for November 7, 2024, this panel will provide recommendations and vote…
Frontier Airlines Soars to Success: A Playful Peek at their Third Quarter 2024 Financial Results!
Frontier Group Holdings, Inc. Reports Strong Financial Results Denver, Oct. 29, 2024 /PRNewswire/ Financial Highlights: Total operating revenues for the third quarter of 2024 reached $935 million, showing a 6 percent increase compared to the same period in 2023. This growth was driven by a 4 percent increase in capacity, showcasing Frontier Group Holdings, Inc.’s…
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Biora Therapeutics Announces Stock Offering Introduction SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that it has entered into definitive agreements for the purchase and sale of 745,342 shares of the Company’s common stock at an offering price of $4.025 per share…
Unleashing the Power of CervoMed: Join Us for an Exciting Oral Presentation at the 8th International Lewy Body Dementia Conference!
CervoMed Inc. Announces Presentation of RewinD-LB Phase 2b Study Data at ILBDC Conference Topline Data Expected in December 2024 BOSTON, Oct. 29, 2024 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company specializing in treatments for age-related neurologic disorders, has disclosed that they will be sharing detailed safety and efficacy results from the completed…
Mark your calendars! BrainsWay’s Third Quarter 2024 Financial Results are coming on November 12, 2024 – get ready to geek out with us!
Welcome to the latest news in mental health technology! Exciting Updates from BrainsWay Ltd. BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its third quarter…
Inverite Reaches New Milestone with Mortgage Automator: Over 200 Private Lenders and Mortgage Investment Corporations Now on Proprietary Open Banking Platform
Inverite Insights Inc. Reports Rapid Adoption of Open Banking Platform Vancouver, British Columbia–(Newsfile Corp. – October 29, 2024) – Inverite Insights Inc. (CSE: INVR) (OTC Pink: INVRF) (FSE: 2V00) (“Inverite” or the “Company”), a leading AI-driven software provider utilizing real-time financial data to empower credit facilitators to transact more effectively with consumers is excited to…